| NCT#: | NCT05174169 |
| NCT QR Code |  |
| Title: | NRG-GI008 – Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US) |
| Protocol: | NRG-GI008 |
| Cancer Type: | Colon Cancer |
| Study Sponsor: | NRG Oncology |
| Brief Summary: | This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer. |
| Study Type: | Interventional |
| Date Opened at SVH: | opening soon |
| Recruitment Status: | opening soon |
| Study Population: | |
| Eligibility Criteria: | See SCHEMA |
| Principal Investigator: | Geetha N. Varma, MD, Oncology, Salinas Valley Health Cancer Care, (831) 755-1701 |
| Participating Institution: | Salinas Valley Health |
| Salinas Valley Health Clinical Research Program: | Terri Nielsen, MSJ, RN, CCRP, Clinical Research Program Manager, research@salinasvalleyhealth.com |
| Link to ClinicalTrials.gov: | https://clinicaltrials.gov/ct2/show/study/NCT05174169 |
| Schema | Schema |
(Tumor Board) & Other Clinical Trials at Salinas Valley Health
